CH471828A - Verfahren zur Herstellung neuer 1,2a-Methylen-5a-androstanderivate - Google Patents

Verfahren zur Herstellung neuer 1,2a-Methylen-5a-androstanderivate

Info

Publication number
CH471828A
CH471828A CH445065A CH445065A CH471828A CH 471828 A CH471828 A CH 471828A CH 445065 A CH445065 A CH 445065A CH 445065 A CH445065 A CH 445065A CH 471828 A CH471828 A CH 471828A
Authority
CH
Switzerland
Prior art keywords
methylene
preparation
new
androstane derivatives
androstane
Prior art date
Application number
CH445065A
Other languages
German (de)
English (en)
Inventor
Rolf Dr Wiechert
Hans Dr Mueller
Friedmund Dr Neumann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH471828A publication Critical patent/CH471828A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CH445065A 1964-04-25 1965-03-31 Verfahren zur Herstellung neuer 1,2a-Methylen-5a-androstanderivate CH471828A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESCH35037A DE1226574B (de) 1964-04-25 1964-04-25 Verfahren zur Herstellung von 1, 2alpha-Methylen-5alpha-androstanderivaten

Publications (1)

Publication Number Publication Date
CH471828A true CH471828A (de) 1969-04-30

Family

ID=7433348

Family Applications (1)

Application Number Title Priority Date Filing Date
CH445065A CH471828A (de) 1964-04-25 1965-03-31 Verfahren zur Herstellung neuer 1,2a-Methylen-5a-androstanderivate

Country Status (5)

Country Link
US (1) US3354185A (xx)
CH (1) CH471828A (xx)
DE (1) DE1226574B (xx)
GB (1) GB1029749A (xx)
NL (1) NL6505072A (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470156A (en) * 1967-01-30 1969-09-30 Smithkline Corp 6,6-ethylene-1,2-methylenesteroids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3163663A (en) * 1961-12-04 1964-12-29 Syntex Corp 2alpha-methyl-delta3-androstene-17-hydrocarbon derivatives
US3254099A (en) * 1962-03-05 1966-05-31 Rhone Poulenc Sa 17alpha-substituted-17beta-hydroxy androstane and androstene derivatives
DE1187611B (de) * 1963-07-13 1965-02-25 Schering Ag Verfahren zur Herstellung von 3-Estern bzw. 3-AEthern des 1alpha, 2alpha-Methylen-delten-3, 17beta-diols und ihrer 17beta-Ester

Also Published As

Publication number Publication date
US3354185A (en) 1967-11-21
DE1226574B (de) 1966-10-13
NL6505072A (xx) 1965-10-26
GB1029749A (en) 1966-05-18

Similar Documents

Publication Publication Date Title
CH477462A (de) Verfahren zur Herstellung neuer Diazacycloalkane
CH451172A (de) Verfahren zur Herstellung neuer substituierter Phenylamino-1,3-diazacyclopentene-(2)
AT257570B (de) Verfahren zur Herstellung von 1,2,4-Trimethyl-5-isopropylbenzol
CH467798A (de) Verfahren zur Herstellung neuer 1,3-Dioxan-Derivate
AT262984B (de) Verfahren zur Herstellung neuer basisch substituierter Naphthalin-(1,4,5,8)-tetracarbonsäurediimide
CH471117A (de) Verfahren zur Herstellung neuer Benzolsulfonylharnstoffe
CH471136A (de) Verfahren zur Herstellung neuer 1,3-Dihydro-5-aryl-2H-1,4-benzodiazepin-2-on-4-oxyde
CH472390A (de) Verfahren zur Herstellung neuer Benzolsulfonylharnstoffe
AT280493B (de) Verfahren zur Herstellung neuer Gona-4,9,11-triene
CH471828A (de) Verfahren zur Herstellung neuer 1,2a-Methylen-5a-androstanderivate
CH505807A (de) Verfahren zur Herstellung neuer 8,14-seco-B-Homogonane
CH487901A (de) Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone
CH467257A (de) Verfahren zur Herstellung neuer Isatin-B-Thiosemicarbazone
AT295515B (de) Verfahren zur Herstellung neuer 3,5-Dioxo-pyrazolidine
CH478116A (de) Verfahren zur Herstellung neuer 9,10-Dihydro-9-hydroxy-10,10-dimethyl-anthracen-derivate
CH455776A (de) Verfahren zur Herstellung neuer 9,10-Dihydro-10,10-dimenthyl-anthracen-derivate
AT273074B (de) Verfahren zur Herstellung neuer 1,1-Dihydroxyphenylpropyl-3-thioäther
AT253146B (de) Verfahren zur Herstellung neuer 17-Hydroxyöstra-1, 3, 5 (10)-trien-[16c-17]-dihydropyrazole
CH459193A (de) Verfahren zur Herstellung neuer 1-Methyl- 1-5a-androsten-17B-ol-3-on-17-ester
AT250967B (de) Verfahren zur Herstellung neuer Derivate des 1, 2-Malonyl-1, 2-dihydrocinnolins
CH457441A (de) Verfahren zur Herstellung von 3,8-Diazabicyclooctanderivaten von Phenothiazinen
CH481890A (de) Verfahren zur Herstellung neuer Benzolsulfonylharnstoffe
CH481129A (de) Verfahren zur Herstellung neuer 3,1-Benzothiazin-Derivate
AT268560B (de) Verfahren zur Herstellung neuer 3-Oxo-2-oxa-4,9,11-gonatriene
CH449023A (de) Verfahren zur Herstellung 5-basisch substituierter 5,6-Dihydro-6-oxomorphanthridine

Legal Events

Date Code Title Description
PL Patent ceased